Genexine stock lifted upon US FDA okays GX-I7 combination therapy trial

Shares of Genexine Inc. Tuesday were lifted by overnight news that the South Korean biotech firm gained clearance in the United States to administer clinical trial of its immunotherapeutic drug candid [전체본문 2020-08-27 15:25:00Z]